Related Experiment Video
Updated: Nov 9, 2025

Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells
Published on: September 1, 2019
Deregulation of enhancer structure, function, and dynamics in acute lymphoblastic leukemia
Laura Belver1, Robert Albero2, Adolfo A Ferrando3
1Institute for Cancer Genetics, Columbia University, New York, NY, 10032, USA; Josep Carreras Leukaemia Research Institute, Badalona, Barcelona, 08916, Spain.
Enhancers regulate gene expression crucial for lymphoid development. Aberrant enhancer activity drives acute lymphoblastic leukemia (ALL) by activating oncogenes, offering potential therapeutic targets.
Area of Science:
- Molecular Biology
- Developmental Biology
- Cancer Biology
Background:
- Enhancers are critical regulatory elements controlling gene expression during lymphoid development.
- Dysregulation of enhancers, including hijacking and aberrant activation, contributes to oncogenic transcriptional circuitry.
- These alterations are implicated in the malignant transformation of lymphoid progenitors in acute lymphoblastic leukemia (ALL).
Purpose of the Study:
- To review recent discoveries on the role of enhancer dynamics in lymphoid development.
- To discuss how genetic and epigenetic alterations in enhancer function promote leukemogenesis.
- To explore potential strategies for targeting enhancer machinery in ALL treatment.
Main Methods:
- Review of current literature on enhancer function in lymphoid development and ALL.
- Analysis of genetic and epigenetic mechanisms affecting enhancer activity.
- Discussion of therapeutic strategies targeting enhancer machinery.
Main Results:
- Enhancer dynamics are essential for normal lymphoid development.
- Altered enhancer activity, through hijacking or aberrant activation, drives oncogene expression in ALL.
- These changes create self-perpetuating oncogenic transcriptional circuits.
Conclusions:
- Enhancer dysregulation is a key driver of acute lymphoblastic leukemia.
- Understanding enhancer dynamics provides insights into leukemogenesis.
- Targeting enhancer machinery represents a promising therapeutic avenue for ALL.
More Related Videos
Related Concept Videos
RNA Polymerase II Accessory Proteins
Epigenetic Regulation
X-chromosome...
Lineage Commitment
Regulation of Hematopoietic Stem Cells

